Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects. 1992

E Spina, and M Ancione, and A E Di Rosa, and M Meduri, and A P Caputi
Institute of Pharmacology, University of Messina, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D003647 Debrisoquin An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. Debrisoquine,Tendor
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

E Spina, and M Ancione, and A E Di Rosa, and M Meduri, and A P Caputi
January 1986, Progress in clinical and biological research,
E Spina, and M Ancione, and A E Di Rosa, and M Meduri, and A P Caputi
January 1991, European journal of clinical pharmacology,
E Spina, and M Ancione, and A E Di Rosa, and M Meduri, and A P Caputi
June 1990, Annals of medicine,
E Spina, and M Ancione, and A E Di Rosa, and M Meduri, and A P Caputi
January 1991, European journal of cancer (Oxford, England : 1990),
E Spina, and M Ancione, and A E Di Rosa, and M Meduri, and A P Caputi
February 1982, Clinical pharmacology and therapeutics,
E Spina, and M Ancione, and A E Di Rosa, and M Meduri, and A P Caputi
January 1991, Oncology,
E Spina, and M Ancione, and A E Di Rosa, and M Meduri, and A P Caputi
January 1988, Cancer chemotherapy and pharmacology,
E Spina, and M Ancione, and A E Di Rosa, and M Meduri, and A P Caputi
February 1990, British journal of clinical pharmacology,
E Spina, and M Ancione, and A E Di Rosa, and M Meduri, and A P Caputi
July 1991, Acta psychiatrica Scandinavica,
E Spina, and M Ancione, and A E Di Rosa, and M Meduri, and A P Caputi
October 1977, Lancet (London, England),
Copied contents to your clipboard!